NCT02183220View on ClinicalTrials.gov

Efficacy and Tolerability of Metamizol in Patients With Episodic Moderate Headache

PHASE3CompletedINTERVENTIONAL
Enrollment

417

Participants

Timeline

Start Date

October 31, 1998

Primary Completion Date

July 31, 1999

Conditions
Migraine Disorders
Interventions
DRUG

Metamizol

DRUG

Acetylsalicylic acid (ASA)

DRUG

Metamizol placebo

DRUG

ASA placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02183220 - Efficacy and Tolerability of Metamizol in Patients With Episodic Moderate Headache | Biotech Hunter | Biotech Hunter